Association of metformin with lower atrial fibrillation risk among patients with type 2 diabetes mellitus: a population-based dynamic cohort and in vitro studies

Time trend analysis of the prevalence and incidence of diagnosed type 2 diabetes among adults in Taiwan from 2000 to 2007: a population-based study

(2013) Cheng-Chieh Lin et al.   BMC PUBLIC HEALTH

The combined effect of metformin and l-cysteine on inflammation, oxidative stress and insulin resistance in streptozotocin-induced type 2 diabetes in rats

(2013) Zenat K. Salman et al.   EUROPEAN JOURNAL OF PHARMACOLOGY

Blockade of reactive oxygen species and Akt activation is critical for anti-inflammation and growth inhibition of metformin in phosphatase and tensin homolog-deficient RAW264.7 cells

(2013) Chiou-Feng Lin et al.   IMMUNOPHARMACOLOGY AND IMMUNOTOXICOLOGY

Hypoglycaemic episodes and risk of dementia in diabetes mellitus: 7-year follow-up study

(2013) C.-H. Lin et al.   JOURNAL OF INTERNAL MEDICINE

Metformin Attenuates the Exacerbation of the Allergic Eosinophilic Inflammation in High Fat-Diet-Induced Obesity in Mice

(2013) Marina Ciarallo Calixto et al.   PLoS One

Metformin reduces airway inflammation and remodeling via activation of AMP-activated protein kinase

(2012) Chan Sun Park et al.   BIOCHEMICAL PHARMACOLOGY

Effects of a vildagliptin/metformin combination on markers of atherosclerosis, thrombosis, and inflammation in diabetic patients with coronary artery disease

(2012) Robert Klempfner et al.   Cardiovascular Diabetology

Use of Thiazolidinediones and the Risk of Colorectal Cancer in Patients With Diabetes: A nationwide, population-based, case-control study

(2012) S.-W. Chen et al.   DIABETES CARE

Region-specific gene expression profiles in the left atria of patients with valvular atrial fibrillation

(2012) Yung-Hsin Yeh et al.   HEART RHYTHM

The effects of rosiglitazone and metformin on inflammation and endothelial dysfunction in patients with type 2 diabetes mellitus

(2011) Evren Fidan et al.   ACTA DIABETOLOGICA

Association of the Metabolic Syndrome With Atrial Fibrillation Among United States Adults (from the REasons for Geographic and Racial Differences in Stroke [REGARDS] Study)

(2011) Rikki M. Tanner et al.   AMERICAN JOURNAL OF CARDIOLOGY

Transforming growth factor-β and oxidative stress mediate tachycardia-induced cellular remodelling in cultured atrial-derived myocytes

(2011) Yung-Hsin Yeh et al.   CARDIOVASCULAR RESEARCH

Thiazolidinediones can prevent new onset atrial fibrillation in patients with non-insulin dependent diabetes

(2011) Tze-Fan Chao et al.   INTERNATIONAL JOURNAL OF CARDIOLOGY

Risk for atrial fibrillation in patients with hypertrophic cardiomyopathy: Association with insulin resistance

(2011) Yuji Shigematsu et al.   Journal of Cardiology

Recent advances in the molecular pathophysiology of atrial fibrillation

(2011) Reza Wakili et al.   JOURNAL OF CLINICAL INVESTIGATION

Pathophysiological Mechanisms of Atrial Fibrillation: A Translational Appraisal

(2011) Ulrich Schotten et al.   PHYSIOLOGICAL REVIEWS

Metabolic syndrome and incidence of atrial fibrillation among blacks and whites in the Atherosclerosis Risk in Communities (ARIC) Study

(2010) Alanna M. Chamberlain et al.   AMERICAN HEART JOURNAL

Metabolic Syndrome and Risk of Development of Atrial Fibrillation

(2008) Hiroshi Watanabe et al.   CIRCULATION

Anti-inflammatory effect of antidiabetic thiazolidinediones prevents bone resorption rather than cartilage changes in experimental polyarthritis

(2008) Meriem Koufany et al.   ARTHRITIS RESEARCH & THERAPY